Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Bioresearch Monitoring Program Should Evaluate Hiring And Retention Strategies, GAO Says
Apr 05 2024
•
By
Sue Sutter
The number of FDA clinical research inspections conducted each year has declined since 2017. • Source: Shutterstock
More from Clinical Trials
More from R&D